Jia Jie Biomedical Co Ltd Cash Flow-to-Debt Ratio
Jia Jie Biomedical Co Ltd cash flow-to-debt ratio. Jia Jie Biomedical Co Ltd (4109) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of NT$12.96 Million could theoretically repay 0% of its total liabilities (NT$220.89 Million) in one year. Check 4109 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jia Jie Biomedical Co Ltd (2015–2025)
Cash flow-to-debt ratio of Jia Jie Biomedical Co Ltd from 2015 to 2025. Historical debt coverage capacity for Jia Jie Biomedical Co Ltd across 11 annual periods. Check Jia Jie Biomedical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Jia Jie Biomedical Co Ltd Cash Flow-to-Debt Ratio by Year (2015–2025)
Jia Jie Biomedical Co Ltd cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Jia Jie Biomedical Co Ltd. For the full cash flow conversion analysis, see Jia Jie Biomedical Co Ltd (4109) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | NT$21.34 Million | NT$174.89 Million | ▼ -66.1% |
| 2024 | 0.36x | NT$44.35 Million | NT$123.08 Million | ▲ +2851.1% |
| 2023 | -0.01x | NT$-4.49 Million | NT$342.69 Million | ▲ +88.1% |
| 2022 | -0.11x | NT$-8.78 Million | NT$80.00 Million | ▼ -317.0% |
| 2021 | 0.05x | NT$4.37 Million | NT$86.47 Million | ▼ -84.8% |
| 2020 | 0.33x | NT$27.10 Million | NT$81.44 Million | ▲ +116.7% |
| 2019 | 0.15x | NT$24.71 Million | NT$160.92 Million | ▲ +574.2% |
| 2018 | -0.03x | NT$-13.10 Million | NT$404.40 Million | ▼ -46.6% |
| 2017 | -0.02x | NT$-13.73 Million | NT$621.58 Million | ▲ +80.2% |
| 2016 | -0.11x | NT$-76.54 Million | NT$684.91 Million | ▼ -181.0% |
| 2015 | 0.14x | NT$82.22 Million | NT$595.84 Million | — |